Treatment improvement and better patient care: which is the most important one in oral cavity cancer?

Radiation Oncology

Vincenzo Tombolini¹  Marco De Vincentiis⁴  Mario Tombolini⁴  Andrea Cassoni²  Valentino Valentini²  Valentina Terenzi²  Daniela Musio³  Francesca De Felice³ 

[1] Spencer-Lorillard Foundation, Viale Regina Elena 262, Rome, 00161, Italy;Department of Maxillofacial Surgery, Policlinico Umberto I “Sapienza”, University of Rome, Viale Regina Elena 326, Rome, 00161, Italy;Department of Radiotherapy, Policlinico Umberto I “Sapienza”, University of Rome, Viale Regina Elena 326, Rome, 00161, Italy;Department Organs of Sense, Policlinico Umberto I “Sapienza”, University of Rome, Viale Regina Elena 326, Rome, 00161, Italy

关键词: Quality of life;    Patient care;    Surgery;    Radiotherapy;    Head and neck;    Cancer;    Oral cavity;    Treatment;   

Others  :  1150860
DOI  :  10.1186/s13014-014-0263-x

 received in 2014-09-07, accepted in 2014-11-15,  发布年份 2014

【 摘 要 】

Due to substantial improvement in diagnosis and treatment of oral cavity cancer, a better understanding of the patient care needs to be revised. We reviewed literature related to OCC and discussed current general management approaches and related long-term radiation toxicities to emphasize the multidisciplinary team involvement. New technical modalities and patient quality of life parameters should be an integral and paramount state in the clinical evaluation to significantly contribute to reduce secondary side effects.

【 授权许可】

   
2014 De Felice et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Siegel R, Ma J, Zou Z, Jemal A: Cancer statistics, 2014. CA Cancer J Clin 2014, 64:9-29.
• [2]Périé S, Meyers M, Mazzaschi O, De Crouy CO, Baujat B, Lacau St Guily J: Epidemiology and anatomy of head and neck cancers. Bull Cancer 2014, 101(5):404-410.
• [3]Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, Clifford GM: Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer 2012, 131(10):2349-2359.
• [4]Isayeva T, Li Y, Maswahu D, Brandwein-Gensler M: Human papillomavirus in non-oropharyngeal head and neck cancers: a systematic literature review. Head Neck Pathol 2012, 6(Suppl 1):S104-S120.
• [5]Grégoire V, Ang K, Budach W, Grau C, Hamoir M, Langendijk JA, Lee A, Le QT, Maingon P, Nutting C, O'Sullivan B, Porceddu SV, Lengele B: Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol 2014, 110(1):172-181.
• [6]Halperin EC, Brady LW, Perez CA, Wazer DE: Principles and Practice of Radiation Oncology. 6th edition. Lippincott Williams and Wilkins, Philadelphia; 2013.
• [7]Edge S, Byrd D, Compton C: AJCC Cancer Staging Manual. 7th edition. Springer, New York, NY, USA; 2009.
• [8]Hiratsuka H, Miyakawa A, Nakamori K, Kido Y, Sunakawa H, Kohama G: Multivariate analysis of occult lymph node metastasis as a prognostic indicator for patients with squamous cell carcinoma of the oral cavity. Cancer 1997, 80(3):351-356.
• [9]Dwivedi RC, Dwivedi RC, Kazi R, Kanwar N, Nutting CM, Harrington KJ, Rhys-Evans PH: Should the treatment paradigms for oral and oropharyngeal cancers be changed now: the role of human papilloma virus? ANZ J Surg 2011, 81(9):581-583.
• [10]Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, Ozsahin EM, Jacobs JR, Jassem J, Ang KK, Lefèbvre JL: Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 2005, 27(10):843-850.
• [11]National Comprehensive Cancer Network Guidelines Head and Neck Version 2.2014. [http://www.nccn.org/]
• [12]Cousins N, MacAulay F, Lang H, MacGillivray S, Wells M: A systematic review of interventions for eating and drinking problems following treatment for head and neck cancer suggests a need to look beyond swallowing and trismus. Oral Oncol 2013, 49(5):387-400.
• [13]van der Molen L, van Rossum MA, Burkhead LM, Smeele LE, Hilgers FJ: Functional outcomes and rehabilitation strategies in patients treated with chemoradiotherapy for advanced head and neck cancer: a systematic review. Eur Arch Otorhinolaryngol 2009, 266(6):889-900.
• [14]Gritz ER, Carr CR, Rapkin D, Abemayor E, Chang LJ, Wong WK, Belin TR, Calcaterra T, Robbins KT, Chonkich G: Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1993, 2(3):261-270.
• [15]Slaughter DP, Southwich HW, Smejkal W: Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 1953, 6(5):963-968.
• [16]Day GL, Blot WJ: Second primary tumors in patients with oral cancer. Cancer 1992, 70(1):14-19.
• [17]Languis JA, van Dijk AM, Doornaert P, Kruizenga HM, Langendijk JA, Leemans CR, Weijs PJ, Verdonck-de Leeuw IM: More than 10% weight loss in head and neck cancer patients during radiotherapy is independently associated with deterioration in quality of life. Nutr Cancer 2013, 65(1):76-83.
• [18]Nguyen NP, North D, Smith HJ, Dutta S, Alfieri A, Karlsson U, Lee H, Martinez T, Lemanski C, Nguyen LM, Ludin A, Sallah S: Safety and effectiveness of prophylactic gastrostomy tubes for head and neck cancer patients undergoing chemoradiation. Surg Oncol 2006, 15(4):199-203.
• [19]Ghezzi EM, Lange LA, Ship JA: Determination of variation of stimulated salivary flow rates. J Dent Res 2000, 79(11):1874-1878.
• [20]Kontis T, Johns M: Anatomy and Physiology of the Salivary Glands. In Head and Neck Surgery – Otolaryngology. 2nd edition. Edited by Bailey BJ. Lippincott Williams and Wilkins, Philadelphia; 2001.
• [21]Trotti A, Eisbruch A: Reducing xerostomia through advanced technology. Lancet Oncol 2011, 12(2):110-111.
• [22]Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP: Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 2003, 14(3):199-212.
• [23]Bergonie J: Sur quelques formes de reactions precoces apres des irradiations. Arch Elect Med 1911, 19:241-245.
• [24]Konings AW, Faber H, Cotteleer F, Vissink A, Coppes RP: Secondary radiation damage as the main cause for unexpected volume effects: a histopathologic study of parotid gland. Int J Radiat Oncol Biol Phys 2006, 64(1):98-105.
• [25]Coppes RP, Roffel AF, Zeilstra LJ, Vissink A, Konings AW: Early radiation effects on muscarinic receptor-induced secretory responsiveness of the parotid gland in the freely moving rat. Radiat Res 2000, 153(3):339-346.
• [26]Nagler RM: The enigmatic mechanism of irradiation-induced damage to the major salivary glands. Oral Dis 2002, 8(3):141-146.
• [27]Abok K, Brunk U, Jung B, Ericsson J: Morphologic and histochemical studies on the differing radiosensitivity of ductular and acinar cells of the rat submandibular gland. Virchows Arch B Cell Pathol Incl Mol Pathol 1984, 45(4):443-460.
• [28]Konings AW, Coppes RP, Vissink A: On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys 2005, 62(4):1187-1194.
• [29]Messmer MB, Thomsen A, Kirste S, Becker G, Momm F: Xerostomia after radiotherapy in the head & neck area: long-term observations. Radiother Oncol 2011, 98(1):48-50.
• [30]Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, Miles EA, Miah AB, Newbold K, Tanay M, Adab F, Jefferies SJ, Scrase C, Yap BK, A'Hern RP, Sydenham MA, Emson M, Hall E: PARSPORT trial management group: Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011, 12(2):127-136.
• [31]Brizel DM, Wasserman TH, Henke M, Strnad V, Rudat V, Monnier A, Eschwege F, Zhang J, Russell L, Oster W, Sauer R: Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J Clin Oncol 2000, 18(19):3339-3345.
• [32]Burlage FR, Roesink JM, Kampinga HH, Coppes RP, Terhaard C, Langendijk JA, van Luijk P, Stokman MA, Vissink A: Protection of salivary function by concomitant pilocarpine during radiotherapy: a double-blind, randomized, placebo-controlled study. Int J Radiat Oncol Biol Phys 2008, 70(1):14-22.
• [33]Pringle S, Van Os R, Coppes RP: Concise review: adult salivary gland stem cells and a potential therapy for xerostomia. Stem Cells 2013, 31(4):613-619.
• [34]Beekhuis GJ, Harrington EB: Trismus. Etiology and management of inability to open the mouth. Laryngoscope 1965, 75:1234-1258.
• [35]Dhanrajani PJ, Jonaidel O: Trismus: aetiology, differential diagnosis and treatment. Dent Update 2002, 29(2):88-92. 94
• [36]Delanian S, Lefaix JL: The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol 2004, 73(2):119-131.
• [37]Wang CJ, Huang EY, Hsu HC, Chen HC, Fang FM, Hsiung CY: The degree and time-course assessment of radiation-induced trismus occurring after radiotherapy for nasopharyngeal cancer. Laryngoscope 2005, 115(8):1458-1460.
• [38]Hsieh LC, Chen JW, Wang LY, Tsang YM, Shueng PW, Liao LJ, Lo WC, Lin YC, Tseng CF, Kuo YS, Jhuang JY, Tien HJ, Juan HF, Hsieh CH: Predicting the severity and prognosis of trismus after intensity-modulated radiation therapy for oral cancer patients by magnetic resonance imaging. PLoS One 2014, 9(3):e92561.
• [39]Dijkstra PU, Kalk WW, Roodenburg JL: Trismus in head and neck oncology: a systematic review. Oral Oncol 2004, 40(9):879-889.
• [40]Johnson J, van As-Brooks CJ, Fagerberg-Mohlin B, Finizia C: Trismus in head and neck cancer patients in Sweden: incidence and risk factors. Med Sci Monit 2010, 16(6):CR278-CR282.
• [41]Goldstein M, Maxymiw WG, Cummings BJ, Wood RE: The effects of antitumor irradiation on mandibular opening and mobility: a prospective study of 58 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999, 88(3):365-373.
• [42]Chen WC, Hwang TZ, Wang WH, Lu CH, Chen CC, Chen CM, Weng HH, Lai CH, Chen MF: Comparison between conventional and intensity-modulated post-operative radiotherapy for stage III and IV oral cavity cancer in terms of treatment results and toxicity. Oral Oncol 2009, 45(6):505-510.
• [43]Gomez DR, Zhung JE, Gomez J, Chan K, Wu AJ, Wolden SL, Pfister DG, Shaha A, Shah JP, Kraus DH, Wong RJ, Lee NY: Intensity-modulated radiotherapy in postoperative treatment of oral cavity cancers. Int J Radiat Oncol Biol Phys 2009, 73(4):1096-1103.
• [44]Hsiung CY, Huang EY, Ting HM, Huang HY: Intensity-modulated radiotherapy for nasopharyngeal carcinoma: the reduction of radiation-induced trismus. Br J Radiol 2008, 81(970):809-814.
• [45]Kamstra JI, Roodenburg JL, Beurskens CH, Reintsema H, Dijkstra PU: TheraBite exercises to treat trismus secondary to head and neck cancer. Support Care Cancer 2013, 21(4):951-957.
• [46]Hartl DM, Cohen M, Juliéron M, Marandas P, Janot F, Bourhis J: Botulinum toxin for radiation-induced facial pain and trismus. Otolaryngol Head Neck Surg 2008, 138(4):459-463.
• [47]Bhrany AD, Izzard M, Wood AJ, Futran ND: Coronoidectomy for the treatment of trismus in head and neck cancer patients. Laryngoscope 2007, 117(11):1952-1956.
• [48]Silva AR, Alves FA, Antunes A, Goes MF, Lopes MA: Patterns of demineralization and dentin reactions in radiation-related caries. Caries Res 2009, 43(1):43-49.
• [49]Walker MP, Wichman B, Cheng AL, Coster J, Williams KB: Impact of radiotherapy dose on dentition breakdown in head and neck cancer patients. Pract Radiat Oncol 2011, 1(3):142-148.
• [50]Vissink A, Burlage FR, Spijkervet FK, Jansma J, Coppes RP: Prevention and treatment of the consequences of head and neck radiotherapy. Crit Rev Oral Biol Med 2003, 14(3):213-225.
• [51]Jansma J, Vissink A, Jongebloed WL, Retief DH, Johannes's-Gravenmade E: Natural and induced radiation caries: A SEM study. Am J Dent 1993, 6(3):130-136.
• [52]Kielbassa AM, Hinkelbein W, Hellwig E, Meyer-Luckel H: Radiation-related damage dentition. Lancet Oncol 2006, 7(4):326-335.
• [53]Franzel W, Gerlach R, Heun HJ, Schaller HG: Effect of tumor therapeutic irradiation on the mechanical properties of teeth tissue. Z Med Phys 2006, 16(2):148-154.
• [54]Pioch T, Golfels D, Staehle HJ: An experimental study of the stability of irradiated teeth in the region of the dentinoenamel junction. Endod Dent Traumatol 1992, 8(6):241-244.
• [55]Reuther T, Schuster T, Mende U, Kübler A: Osteoradionecrosis of the jaws as a side effect of radiotherapy of head and neck tumour patients–a report of a thirty year retrospective review. Int J Oral Maxillofac Surg 2003, 32(3):289-295.
• [56]Marx RE: Osteoradionecrosis: a new concept of its pathophysiology. J Oral Maxillofac Surg 1983, 41(5):283-288.
• [57]Wong JK, Wood RE, McLean M: Conservative management of osteoradionecrosis. Oral Surg Oral Med Pathol Oral Radiol Endod 1997, 84(1):16-21.
• [58]Bras J, de Jonge HK, van Merkesteyn JP: Osteoradionecrosis of the mandible: pathogenesis. Am J Otolaryngol 1990, 11(4):244-250.
• [59]Thiel HJ: Osteoradionecrosis. I. Etiology, pathogenesis, clinical aspects and risk factors. Radiobiol Radiother (Berl) 1989, 30(5):397-413.
• [60]Regaud C: Sur la necrose des os attente par un processus cancereux et traits par les radiations. Compt Rend Soc Biol 1922, 87:629.
• [61]Marx RE: A new concept in the treatment of osteoradionecrosis. J Oral Maxillofac Surg 1983, 41(6):351-357.
• [62]Epstein JB, Wong FL, Stevenson-Moore P: Osteoradionecrosis: clinical experience and a proposal for classification. J Oral Maxillofac Surg 1987, 45(2):104-110.
• [63]Schwartz HC, Kagan AR: Osteoradionecrosis of the mandible: scientific basis for clinical staging. Am J Clin Oncol 2002, 25(2):168-171.
• [64]Støre G, Boysen M: Mandibular osteoradionecrosis: clinical behaviour and diagnostic aspects. Clin Otolaryngol Allied Sci 2000, 25(5):378-384.
• [65]Wahl MJ: Osteoradionecrosis prevention myths. Int J Radiat Oncol Biol Phys 2006, 64(3):661-669.
• [66]Ahmed M, Hansen VN, Harrington KJ, Nutting CM: Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefit of intensity modulated radiotherapy in advanced oral cavity carcinoma. Med Dosim 2009, 34(3):217-224.
• [67]Chang DT, Sandow PR, Morris CG, Hollander R, Scarborough L, Amdur RJ, Mendenhall WM: Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible? Head Neck 2007, 29(6):528-536.
• [68]Starcke EN, Shannon IL: How critical is the interval between extractions and irradiation in patients with head and neck malignancy? Oral Surg Oral Med Oral Pathol 1997, 43(3):333-337.
• [69]Anderson L, Meraw S, Al-Hezaimi K, Wang HL: The influence of radiation therapy on dental implantology. Implant Dent 2013, 22(1):31-38.
• [70]Delanian S, Depondt J, Lefaix JL: Major healing of refractory mandible osteoradionecrosis after treatment combining pentoxifylline and tocopherol: a phase II trial. Head Neck 2005, 27(2):114-123.
• [71]Annane D, Depondt J, Aubert P, Villart M, Géhanno P, Gajdos P, Chevret S: Hyperbaric oxygen therapy for radionecrosis of the jaw: a randomized, placebo-controlled, double-blind trial from the ORN96 study group. J Clin Oncol 2004, 22(24):4893-4900.